Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2003 07:01 ET | Source: Galapagos Genomics

Galapagos Genomics and Degussa Enter into Nutraceutical Research Agreement

MECHELEN, Belgium, April 7, 2003 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, and Degussa BioActives announced today that they have entered into a research...
January 16, 2003 09:51 ET | Source: Galapagos Genomics

Galapagos Launches Gene Silencing Platform at Keystone Symposia

MECHELEN, Belgium, Jan. 16, 2003 (PRIMEZONE) -- Galapagos Genomics, the Belgian functional genomics company, today announced that it has launched its SilenceSelect(TM) gene silencing platform. With...
June 20, 2002 07:49 ET | Source: Galapagos Genomics

Galapagos Genomics Receives Grants to Expand Functional Genomics Platform

MECHELEN, Belgium, June 20, 2002 (PRIMEZONE) -- Galapagos Genomics, the Belgian/Dutch functional genomics company, announced today that it has been awarded technology development grants in Belgium...
May 21, 2002 07:52 ET | Source: Galapagos Genomics

Robin Brown Joins Galapagos Genomics as Chief Scientific Officer

MECHELEN, Belgium, May 21, 2002 (PRIMEZONE) -- Galapagos Genomics NV today announced that Robin Brown has been appointed Chief Scientific Officer (CSO). Dr. Brown will be responsible for directing...
March 05, 2002 07:51 ET | Source: Galapagos Genomics

Galapagos Genomics Raises Euro21.4 Million in Private Placement

MECHELEN, Belgium, March 5, 2002 (PRIMEZONE) -- Galapagos Genomics, the Belgian/Dutch functional genomics company, today announced the completion of a Euro21.4 million private placement. This first...
January 23, 2002 08:27 ET | Source: Galapagos Genomics

Galapagos Genomics and Exelixis Collaborate in Gene Function Analysis

MECHELEN, Belgium, Jan. 23, 2002 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, today announced a research collaboration with Exelixis, Inc., for the use of Galapagos'...
January 23, 2002 08:25 ET | Source: Galapagos Genomics

Galapagos Genomics Receives US Patent for its PhenoSelect Platform

MECHELEN, Belgium, Jan. 23, 2002 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, today announced that it has been awarded US Patent No. 6,340,595 entitled "High...
December 10, 2001 08:20 ET | Source: Galapagos Genomics

Galapagos Genomics and Euroscreen Enter into a Collaboration on G-Protein Coupled Receptors

MECHELEN and BRUSSELS, Belgium, Dec. 10, 2001 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, and Euroscreen SA, the Belgian G-protein coupled receptor (GPCR) company,...
November 14, 2001 07:48 ET | Source: Crucell N.V.

Galapagos Genomics and Pharmacia Enter Three-Year Gene Target Identification Collaboration

MECHELEN, Belgium, Nov. 14, 2001 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, today announced that it has entered into a broad functional genomics collaboration with...
October 22, 2001 08:51 ET | Source: Crucell N.V.

Galapagos Genomics and Procter & Gamble Pharmaceuticals Announce Functional Genomics Collaboration

MECHELEN, Belgium, and CINCINNATI, Oh., USA, Oct. 22, 2001 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, and Procter & Gamble Pharmaceuticals (P&GP), a...